Low serum levels of ghrelin are associated with gallstone disease

World Journal of Gastroenterology

Volumn 12, Issue 18, 2006, Pages 3096-3100

  Méndez Sánchez, Nahum ^a   Ponciano Rodríguez, Guadalupe ^b   Bermejo Martínez, Luisa ^c   Villa, Antonio R ^d   Chávez Tapia, Norberto C ^a   Zamora Valdéz, Daniel ^a   Pichardo Bahena, Raúl ^a   Barredo Prieto, Blanca ^a   Uribe Ramos, Martha H ^a   Ramos, Martha H ^a   Baptista González, Héctor A ^c   Uribe, Misael ^a  

^a LIVER RESEARCH UNIT   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Gallbladder; Gallstones; Gastrointestinal hormones; Ghrelin; Obesity

Indexed keywords

GHRELIN; INSULIN; LIPID; MESSENGER RNA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BODY MASS; CHOLELITHIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; PROBABILITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEX RATIO; STATISTICAL ANALYSIS; STOMACH PROTECTION;

EID: 33744534546     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i19.3096     Document Type: Article

References (31)

1. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999; 130: 671-680
2. Hall MJ, Owings MF. 2000 National Hospital Discharge Survey. Adv Data. 2002; 329:1-18
3. Mendez-Sanchez N, Jessurun J, Ponciano-Rodriguez G, Alonso-de-Ruiz P, Uribe M, Hernandez-Avila M. Prevalence of gallstone disease in Mexico. A necropsy study. Dig Dis Sci 1993; 38: 680-683
4. Mendez-Sanchez N, Gonzalez V, King-Martinez AC, Sanchez H, Uribe M. Plasma leptin and the cholesterol saturation of bile are correlated in obese women after weight loss. J Nutr 2002; 132:2195-2198
5. Bennion LJ, Grundy SM. Effects of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest 1975; 56: 996-1011
6. Mendez-Sanchez N, Gonzalez V, Aguayo P, Sanchez JM, Tanimoto MA, Elizondo J, Uribe M. Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight. J Nutr 2001; 131: 2300-2303
7. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85: 495-522
8. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87. 2988
9. Kojima M, Hosoda H, Matsuo, H, Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001; 12: 118-122
10. Cummings DE, Shannon MH. Roles for ghrelin in the regulation of appetite and body weight. Arch Surg 2003; 138: 389-396
11. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992
12. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913
13. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709
14. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-1630
15. Calvo MM, Bujanda L, Heras I, Calderon A, Cabriada JL, Orive V, Martinez A, Capelastegi A. Magnetic resonance cholangiography versus ultrasound in the evaluation of the gallbladder. J Clin Gastroenterol 2002; 34: 233-236
16. Hernandez-Avila M, Romieu I, Parra S, Hernandez-Avila J, Madrigal H, Willett W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 1998; 40: 133-140
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419
19. Hattori K, Becque MD, Katch VL, Rocchini AP, Boileau RA, Slaughter MH, Lohman TG. Fat patterning of adolescents. Ann Hum Biol 1987; 14: 23-28
20. Sampliner RE, Bennett PH, Comess LJ, Rose FA, Burch TA. Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med 1970; 283:1358-1364
21. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW jr, Taub DD. Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114: 57-66
22. Moschetta A, Twickler TB, Rehfeld JF, van Ooteghem NA, Cabezas MC, Portincasa P, van Berge-Henegouwen GP, van Erpecum KJ. Effects of growth hormone deficiency and recombinant growth hormone therapy on postprandial gallbladder motility and cholecystokinin release. Dig Dis Sci 2004; 49: 529-534
23. Bigg-Wither GW, Ho KK Grunstein RR, Sullivan CE, Doust BD. Effects of long term octreotide on gall stone formation and gall bladder function. BMJ 1992; 304:1611-1612
24. Luiking YC, Peeters TL, Stolk MF, Nieuwenhuijs VB, Portincasa P, Depoortere I, van Berge Henegouwen GP, Akkermans LM. Motilin induces gall bladder emptying and antral contractions in the fasted state in humans. Gut 1998; 42: 830-835
25. Luiking YC, Akkermans LM, van der Reijden AC, Peeters TL, van Berge-Henegouwen GP. Differential effects of motilin on interdigestive motility of the human gastric antrum, pylorus, small intestine and gallbladder. Neurogastroenterol Motil 2003; 15:103-111
26. Stolk MF, Van Erpecum Kj, Peeters TL, Samsom M, Smout AJ, Akkermans LM, Vanberge-Henegouwen GP. Interdigestive gallbladder emptying, antroduodenal motility, and motilin release patterns are altered in cholesterol gallstone patients. Dig Dis Sci 2001; 46:1328-1334
27. Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gall stone disease: a case-control study. Br Med J (Clin Res Ed) 1984; 289: 521-525
28. Nepokroeff CM, Lakshmanan MR, Ness GC, Dugan RE, Porter JW. Regulation of the diurnal rhythm of rat liver betahydroxy-beta-methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone. Arch Biochem Biophys 1974; 160:387-396
29. Osborne AR, Pollock W, Lagor WR, Ness GC. Identification of insulin-responsive regions in the HMG-CoA reductase promoter. Biochem Biophys Res Commun 2004; 318:814-818
30. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005; 11: 1653-1657
31. Langenberg C, Bergstrom J, Laughlin GA, Barrett-Connor E. Ghrelin and the metabolic syndrome in older adults. J Clin Endocrinol Metab 2005; 90: 6448-6453